280 related articles for article (PubMed ID: 9322070)
1. IgM anti-phenolic glycolipid I and IgG anti-10-kDa heat shock protein antibodies in sera and immune complexes isolated from leprosy patients with or without erythema nodosum leprosum and contacts.
Rojas RE; Demichelis SO; Sarno EN; Segal-Eiras A
FEMS Immunol Med Microbiol; 1997 Sep; 19(1):65-74. PubMed ID: 9322070
[TBL] [Abstract][Full Text] [Related]
2. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
3. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G response against 10-kDa and 65-kDa heat-shock proteins in leprosy patients and their household contacts.
Rojas RE; Segal-Eiras A
FEMS Immunol Med Microbiol; 1996 Oct; 15(4):189-98. PubMed ID: 8908480
[TBL] [Abstract][Full Text] [Related]
5. Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.
Beuria MK; Parkash O; Joshi B; Mohanty KK; Katoch K; Sengupta U
Int Arch Allergy Immunol; 1998 Jan; 115(1):61-6. PubMed ID: 9430497
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
7. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
8. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
9. Immune complexes and antibody levels in blisters over human leprosy skin lesions with or without erythema nodosum leprosum.
Scollard DM; Bhoopat L; Kestens L; Vanham G; Douglas JT; Moad J
Clin Immunol Immunopathol; 1992 Jun; 63(3):230-6. PubMed ID: 1623643
[TBL] [Abstract][Full Text] [Related]
10. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
[TBL] [Abstract][Full Text] [Related]
12. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
[TBL] [Abstract][Full Text] [Related]
13. Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil.
Frota CC; Freitas MV; Foss NT; Lima LN; Rodrigues LC; Barreto ML; Kerr LR
Trans R Soc Trop Med Hyg; 2010 Jul; 104(7):490-5. PubMed ID: 20447668
[TBL] [Abstract][Full Text] [Related]
14. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
[TBL] [Abstract][Full Text] [Related]
15. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
[TBL] [Abstract][Full Text] [Related]
16. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories.
Meeker HC; Levis WR; Sersen E; Schuller-Levis G; Brennan PJ; Buchanan TM
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):530-9. PubMed ID: 3546543
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients.
Miller RA; Gorder D; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial carbohydrate antigens for serological testing of patients with leprosy.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Brennan PJ; Fried P
J Infect Dis; 1987 Nov; 156(5):763-9. PubMed ID: 3116103
[TBL] [Abstract][Full Text] [Related]
19. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
[TBL] [Abstract][Full Text] [Related]
20. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens.
Cho SN; Cellona RV; Fajardo TT; Abalos RM; dela Cruz EC; Walsh GP; Kim JD; Brennan PJ
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):25-31. PubMed ID: 2030314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]